**Core Concept**
Mifepristone is a synthetic steroid that acts as an antagonist to the progesterone receptor, thereby inhibiting the progesterone-mediated effects in the body. This unique mechanism of action makes it a valuable agent in various clinical settings, particularly in gynecology and oncology.

**Why the Correct Answer is Right**
Mifepristone has several established indications, including the medical termination of pregnancy, treatment of Cushing's syndrome, and management of advanced uterine fibroids. Its antiprogestin activity allows for the disruption of the normal progesterone-mediated support of endometrial growth, thereby facilitating the termination of pregnancy. Additionally, its antagonism of the glucocorticoid receptor makes it an effective treatment for Cushing's syndrome, a condition characterized by excess cortisol production.

**Why Each Wrong Option is Incorrect**
* **Option A:** Incorrect because mifepristone is actually used in the management of advanced uterine fibroids, not as a treatment for benign prostatic hyperplasia (BPH). BPH is typically managed with 5-alpha reductase inhibitors or alpha-blockers.
* **Option B:** Incorrect because mifepristone has been shown to be effective in the treatment of Cushing's syndrome, not as a treatment for hypertension. While hypertension is a common comorbidity in Cushing's syndrome, mifepristone's primary indication is not for the management of blood pressure.
* **Option C:** Incorrect because mifepristone is not used as a treatment for endometriosis. In fact, its antiprogestin activity may exacerbate endometriosis symptoms. Treatment of endometriosis typically involves hormonal therapies like GnRH agonists or danazol.

**Clinical Pearl / High-Yield Fact**
Mifepristone's unique mechanism of action as an antiprogestin agent makes it a valuable tool in managing conditions characterized by excess progesterone or glucocorticoid activity. Its use in medical termination of pregnancy and treatment of Cushing's syndrome highlights the importance of understanding the progesterone-mediated effects on the endometrium and glucocorticoid receptor activity.

**Correct Answer: A.**